Newcastle University

Introduction

Helen Foster trained in adult rheumatology and subsequently in general paediatrics and paediatric rheumatology. She leads active clinical and educational research programmes focussing on identifying barriers to specialist care, and has developed novel educational tools to facilitate earlier diagnosis and referral. There are numerous research collaborations at international level and an active clinical research portfolio within the CLRN. She is active within BSPAR Executive to champion best practice and Chairs the RCPCH Advisory Committee responsible for Higher Specialist Training in paediatric rheumatology in the UK.

Background

Trained in adult rheumatology and subsequently in general paediatrics and paediatric rheumatology. Clinical Fellowship Paediatric Rheumatology, Vancouver, 1992-3.

Roles and Responsibilities

Academic lead paediatric rheumatology Newcastle University and
Honorary Consultant paediatric and adolescent rheumatologist, Newcastle Hospitals NHS Foundation Trust

Speciality Group Lead Paediatrics - NTW CLRN - 2012 -

Chair Royal College Paediatrics and Child Health Specialist Advisory Committee (Rheumatology) - responsible for national Higher Specialist Training in paediatric rheumatology - 2007-2013 

Scientific and Founding member Arthritis Research UK/MCRN Paediatric Rheumatology Clinical Studies Group (initiative of Medicines for Children Research Network and Arthritis Research UK to develop research strategy for paediatric rheumatology in the UK) - 2009

Representative for National Specialist Commissioning -Paediatric Rheumatology  

British Society for Paediatric and Adolescent Rheumatology Board 2007-2013

Paediatric Rheumatology European Society Training and Education Committee - UK representative 2007-2013

Associate Editor Rheumatology (Oxford)

Steering Group Pediatric Rheumatology Innovations in Medical Education

Qualifications

MBBS (Newcastle) Hons 1985
MRCP 1988
MD 1991
DCH 1995
FRCP 2000
FRCPCH 1997
Cert Med Ed 2002

Previous Positions

Arthritis Research Campaign Clinical Senior Lecturer Paediatric Rheumatologist (2001 - 2007)
NHS Consultant Rheumatologist (1996 - 2001), Newcastle Hospitals NHS Trust
Arthritis Research Campaign Junior Research Fellowship (1989-1991)

Honours and Awards

Abbott - Innovation in Rheumatology - Educational research in rheumatology awarded to Newcastle Educational research group - 2007

National Rheumatoid Arthritis Society (NRAS) Patient in Focus award - Independence weekends for adolescents with rheumatic disease awarded to Newcastle paediatric rheumatology team - 2005

Wyeth "Moving Forwards" - Team award for rheumatology services 2004 

Research Interests

The clinical research programme focusses on understanding the barriers and drivers to paediatric rheumatological care and developing educational tools to faciliate earlier diagnosis and referral to specialist care.

The basic science programme focusses on understanding of biochemical and immunological mechanisms of joint damage and their role as prognostic indicators in early arthritis.

There are also numerous clinical research collaborations within the University, and national and international levels. There is active participation in clinical trials and an active NIHR portfolio. 

Current Work

Barriers to paediatric rheumatology care and educational research within paediatric musculoskeletal medicine to promote access to care

Colloborations within Newcastle University with the Newcastle Musculoskeletal Educational Research, the Institute Health & Society and the School of Medical Education. Collaborations nationally with Manchester University and colleagues within BSPAR. International collaborations with Paediatric Rheumatology International Trials Organisation (PRINTO) and Pediatric Rheumatology Innovations in Musculoskeletal Education (PRIME).

Future Research

Interventional strategies to improve access for care for children with rheumatic disease in resource poor countries

Implementation and evaluation of educational strategies in paediatric musculoskeletal teaching.

Esteem Indicators

Funding

Currently over £1 million grant income. Current Arthritis Research UK projects include:

Improving paediatric musculoskeletal clinical skills in medical students.
A study to develop Regional Musculoskeletal examination for use in school aged children.
Exploring barriers to care for children with Juvenile Idiopathic Arthritis
Paediatric musculoskeletal learning outcomes for trainees in primary care

Undergraduate Teaching

Personal Tutor, Educational supervisor SSC modules paediatric rheumatology. Tutor general paediatrics. Tutor Chronic Illness and Disability Rotation.

Postgraduate Teaching

Postgraduate teaching for General paediatrics, adult Rheumatology, paediatric rheumatology and Primary Care colleagues (locally, regionally and and nationally).

Educational Supervisor to Higher Specialist Trainees in paediatric rheumatology.

• Smith EMD, Foster HE, Beresford MW. Adding to complexity: comorbidity in paediatric rheumatic disease. Rheumatology 2013, 52(1), 22-33.
• Smith E, Molyneux E, Heikens GT, Foster H. Acceptability and practicality of pGALS in screening for rheumatic disease in Malawian children. Clinical Rheumatology 2012, 31(4), 647-653.
• Hawley DP, Baildam EM, Amin TS, Cruikshank MK, Davidson JE, Dixon J, Martin NS, Ohlsson V, Pilkington C, Rangaraj S, Riley P, Sundaramoorthy C, Walsh J, Foster HE. Access to care for children and young people diagnosed with localized scleroderma or juvenile SSc in the UK. Rheumatology 2012, 51(7), 1235-1239.
• Sen E, Chan M, Hardy E, Rapley T, Hensman P, Wraith JE, Foster H. Assessment of musculoskeletal abnormalities in children with mucopolysaccharidoses using a simple musculoskeletal examination (paediatric gait, arms, legs and spine). In: Annual Conference of the British Society for Paediatric and Adolescent Rheumatology (BSPAR). 2012, Edinburgh, UK: Oxford University Press.
• McErlane F, Beresford MW, Baildam EM, Thomson W, Hyrich K, Chieng A, Davidson J, Foster HE, Gardner-Medwin J, Lunt M, Wedderburn L. Does exclusion of the ESR from jadas affect validity in the routine clinical setting?. In: Annual Meeting of the British Society for Rheumatology. 2012, Glasgow, UK: Oxford University Press.
• Malviya A, Ferris CM, Rushton SP, Foster HE, Hanson H, Muthumayandi K, Deehan DJ. Exploring the relationships between adult juvenile idiopathic arthritis and employment. In: Annual Meeting of the British Society for Rheumatology. 2012, Glasgow, UK: Oxford University Press.
• Chan MO, Wyllie R, Foster HE. Inhaled Nitrous Oxide Facilitates Access to Intra-Articular Corticosteroid Injections in Children with Juvenile Idiopathic Arthritis. In: Annual Scientific Meeting of the American College of Rheumatology (ACR). 2012, Washington, DC, USA: John Wiley & Sons, Inc.
• Cordingley L, Vracas T, Baildam E, Chieng A, Davidson J, Foster HE, Gardner-Medwin J, Wedderburn LR, Thomson W, Hyrich KL. Juvenile-onset inflammatory arthritis: a study of adolescents' beliefs about underlying cause. Rheumatology 2012, 51(12), 2239-2245.
• Verstappen S, Cobb J, Foster HE, Baildam E, Wedderburn LR, Gardner-Medwin J, Chieng A, Davidson J, Thomson W, Hyrich KL. Patients with Juvenile Idiopathic Arthritis From a Low Socio-Economic Background Perceive Their Disease Activity and Physical Limitations Higher Than Patients from a High Socio-Economic Background. In: Annual Scientific Meeting of the American College of Rheumatology (ACR). 2012, Washington, DC, USA: John Wiley & Sons, Inc.
• Goff I, Rowan A, Bateman BJ, Foster HE. Poor sensitivity of musculoskeletal history in children. Archives of Disease in Childhood 2012, 97(7), 644-646.
• Goff I, Rowan A, Bateman B, Foster HE. Poor sensitivity of musculoskeletal history in children. Archives of Disease in Childhood 2012, 97(7), 644-646.
• Smith E, Gray W, Taylor-Robinson D, Foster HE, Beresford MW. Predictors of access to care in JSLE: evidence from the UK JSLE cohort study. In: Annual Conference of the British Society for Paediatric and Adolescent Rheumatology (BSPAR). 2012, Edinburgh, UK: Oxford University Press.
• Verstappen S, Wedderburn LR, Foster HE, Baildam E, Gardner-Medwin J, Davidson J, Chieng A, Thomson W, Hyrich KL. Reasons and Predictors of Methotrexate Discontinuation in Children with JIA: Results From the Childhood Arthritis Prospective Study (CAPS). In: Annual Scientific Meeting of the American College of Rheumatology (ACR). 2012, Washington, DC, USA: John Wiley & Sons, Inc.
• Smith E, Anderson M, Foster H. The child with a limp: a symptom and not a diagnosis. Archives of Disease in Childhood: Education and Practice Edition 2012, 97(5), 185-193.
• Malviya A, Rushton SP, Foster HE, Ferris CM, Hanson H, Muthumayandi K, Deehan DJ. The relationships between adult juvenile idiopathic arthritis and employment. Arthritis and Rheumatism 2012, 64(9), 3016-3024.
• Kearsley-Fleet L, Baildam E, Beresford M, Davies R, Foster HE, Mowbray K, Southwood TR, Thomson W, Hyrich KL. Use of non-etanercept biologics in children with JIA: Results from the biologics for children with rheumatic diseases study. In: Annual Conference of the British Society for Paediatric and Adolescent Rheumatology (BSPAR). 2012, Edinburgh, UK: Oxford University Press.
• McErlane F, Beresford MW, Baildam EM, Thomson W, Hyrich K, Chieng A, Davidson J, Foster HE, Gardner-Medwin J, Lunt M, Wedderburn L. Validation of jadas in all subtypes of juvenile idiopathic arthritis in a clinical setting. In: Annual Meeting of the British Society for Rheumatology. 2012, Glasgow, UK: Oxford University Press.
• Lal SD, McDonagh J, Baildam E, Wedderburn LR, Gardner-Medwin J, Foster HE, Chieng A, Davidson J, Adib N, Thomson W, Hyrich KL. Agreement between Proxy and Adolescent Assessment of Disability, Pain, and Well-Being in Juvenile Idiopathic Arthritis. Journal of Pediatrics 2011, 158(2), 307-312.
• Southwood TR, Foster HE, Davidson JE, Hyrich KL, Cotter CB, Wedderburn LR, Hull RG, Venning HE, Rahman JK, Cummins CL, on behalf of the British Society for Adolescent and Paediatric Rheumatology Biologics and New Drugs. Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients. Rheumatology 2011, 50(1), 189-195.
• Baildam EM, Ennis H, Foster HE, Shaw L, Chieng ASE, Kelly J, Herrick AL, Richards HL. Influence of Childhood Scleroderma on Physical Function and Quality of Life. Journal of Rheumatology 2011, 38(1), 167-173.
• Foster HE, Kay LJ, May CR, Rapley TR. Pediatric regional examination of the musculoskeletal system: A practice- and consensus-based approach. Arthritis Care & Research 2011, 63(11), 1503-1510.
• Foster HE, Kay L, May C, Rapley T. Pediatric regional examination of the musculoskeletal system: A practice- and consensus-based approach. Arthritis Care & Research 2011, 63(11), 1503-1510.
• Goff I, Bateman B, Myers A, Foster H. Acceptability and Practicality of Musculoskeletal Examination in Acute General Pediatric Assessment. Journal of Pediatrics 2010, 156(4), 657-662.
• Foster H, Rapley T. Access to Pediatric Rheumatology Care - A Major Challenge to Improving Outcome in Juvenile Idiopathic Arthritis. Journal of Rheumatology 2010, 37(11), 2199–2202.
• Davies K, Cleary AG, Hutchinson E, Foster HE, Baildam E. British Society for Paediatric and Adolescent Rheumatology Standards of Care for children and young people with juvenile idiopathic arthritis. Rheumatology 2010, 49(7), 1406-1408.
• Leone V, Wyllie R, Foster H. Chronic arthritis in children and adolescents. Medicine 2010, 38(4), 177-184.
• Beresford MW, Cleary AG, Foster HE, Hutchinson E, Baildam EM, Davies K. Comment on: Developing standards of care for patients with juvenile idiopathic arthritis. Rheumatology 2010, 49(11), 2227-2229.
• Foster H, Harrison M, Pain C, Symmons D, Baildam E. Delivery of paediatric rheumatology care in the UK-the projected shortfall. Clinical Rheumatology 2010, 30(5), 679-683.
• Hyrich KL, Lal SD, Foster HE, Thornton J, Adib N, Baildam E, Gardner-Medwin J, Wedderburn LR, Chieng A, Davidson J, Thomson W. Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective Study. Rheumatology 2010, 49(1), 116-122.
• Foster H, Rapley T, May C. Juvenile idiopathic arthritis: improved outcome requires improved access to care. Rheumatology 2010, 49(3), 401-403.
• Malviya A, Foster HE, Avery P, Weir DJ, Deehan DJ. Long term outcome following knee replacement in patients with juvenile idiopathic arthritis. The Knee 2010, 17(5), 340-344.
• Foster HE, Ramanan AV. 'The eyes have it!' The need to improve awareness and access to early ophthalmological screening for juvenile idiopathic arthritis associated uveitis. Rheumatology 2009, 48(4), 330-331.
• Abinun M, Flood TJ, Cant AJ, Veys P, Gennery AR, Foster HE, Friswell M, Baildam E, Davidson J, Southwood TR, Livermore P, Wedderburn LR. Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000-2007). Molecular Immunology 2009, 47(1), 46-51.
• Jandial S, Rapley T, Foster H. Current teaching of paediatric musculoskeletal medicine within UK medical schools – a need for change. Rheumatology 2009, 48(5), 587-590.
• Jandial S, Myers A, Wise E, Foster HE. Doctors Likely to Encounter Children with Musculoskeletal Complaints Have Low Confidence in Their Clinical Skills. Journal of Pediatrics 2009, 154(2), 267-271.
• Rapley TJ, May C, Heaven B, Kay LJ, Foster H. Doing being a team: Multidisciplinarity-in-action in paediatric rheumatology consultations. In: British Association for Applied Linguistics - Cambridge University Press Seminar - Connecting Discourses: Academic and Professional Worlds. 2009, Centre for Applied Linguistics, University of Warwick.
• Foster H, Kimura Y. Ensuring that all paediatricians and rheumatologists recognise significant rheumatic diseases. Best Practice and Research: Clinical Rheumatology 2009, 23(5), 625-642.
• Malviya A, Johnson-Lynn S, Avery P, Deehan D, Foster H. Juvenile idiopathic arthritis in adulthood and orthopaedic intervention. Clinical Rheumatology 2009, 28(12), 1411-1417.
• Jandial S, Rapley T, Foster HE. Teaching of paediatric musculoskeletal medicine at UK medical schools – a need for change. Rheumatology 2009, 48(5), 587-590.
• Lorenzi AR, Foster HE, Isaacs JD. Thymic function and immune senescence in juvenile idiopathic arthritis: comment on the article by Prelog et al. Arthritis & Rheumatism 2009, 60(1), 310-311.
• Lorenzi A, Morgan TA, Anderson A, Catterall J, Patterson AM, Foster HE, Isaacs JD. Thymic function in juvenile idiopathic arthritis. Annals of the Rheumatic Diseases 2009, 68(6), 983-900.
• Ohlsson V, Baildam E, Foster HE, Jandial S, Strike H, Ramanan AV. Anakinra treatment for systemic onset juvenile idiopathic arthritis (SOJIA). Rheumatology 2008, 47(4), 555-556.
• Adib N, Hyrich K, Thornton J, Lunt M, Davidson J, Gardner-medwin J, Foster H, Baildam E, Wedderburn L, Thomson W. Association between duration of symptoms and severity of disease at first presentation to paediatric rheumatology: Results from the Childhood Arthritis Prospective Study. Rheumatology 2008, 47(7), 991-995.
• Thornton J, Lunt M, Ashcroft D, Baildam E, Foster H, Davidson J, Gardner-medwin J, Beresford M, Symmons D, Thomson W, Elliott R. Costing juvenile idiopathic arthritis: Examining patient-based costs during the first year after diagnosis. Rheumatology 2008, 47(7), 985-990.
• Jandial S, Foster HE. Examination of the musculoskeletal system in children - a simple approach. Paediatrics and Child Health 2008, 18(2), 47-55.
• Lorenzi AR, Foster HE, Isaacs JD. Thymic function and immune senescence in juvenile idiopathic arthritis. Arthritis & Rheumatism 2008, 60(1), 310-311.
• Foster HE, Eltringham MS, Kay LJ, Friswell M, Abinun M, Myers A. Delay in access to appropriate care for children presenting with musculoskeletal symptoms and ultimately diagnosed with juvenile idiopathic arthritis. Arthritis Care and Research 2007, 57(6), 921-927.
• Jandial S, Foster HE. How do we improve paediatric rheumatology training? A UK perspective. Arthritis Rheumatism 2007, 57(7), 1340-1341.
• Wood M, Wyllie R, Foster HE. A Balancing Act. Archives of Disease in Childhood - Education and Practice 2006, 91(3), ep68-ep74.
• Peake NJ, Foster HE, Khawaja K, Cawston TE, Rowan AD. Assessment of the clinical significance of gelatinase activity in patients with juvenile idiopathic arthritis using quantitative protein substrate zymography. Annals of the Rheumatic Diseases 2006, 65(4), 501-507.
• Foster H, Davidson J, Baildam E, Abinun M, Wedderburn LR. Autologous haematopoeitic stem cell rescue (AHSCR) for severe rheumatic disease in children: Guidance for BSPAR members - Executive summary. Rheumatology 2006, 45(12), 1570-1571.
• Ferreira RA, Vastert SJ, Abinun M, Foster HE, Modesto C, Olive T, Kuis W, Wulffraat NM. Hemophagocytosis during fludarabine-based SCT for systemic juvenile idiopathic arthritis. Bone Marrow Transplantation 2006, 38(3), 249-251.
• Peake NJ, Khawaja K, Myers A, Nowell MA, Jones SA, Rowan AD, Cawston TE, Foster HE. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor. Rheumatology 2006, 45(12), 1485-1489.
• Foster HE, Cabral DA. Is musculoskeletal history and examination so different in paediatrics?. Best Practice and Research: Clinical Rheumatology 2006, 20(2), 241-262.
• Foster HE, Kay LJ, Friswell M, Coady D, Myers A. Musculoskeletal screening examination (pGALS) for school-age children based on the adult GALS screen. Arthritis Care and Research 2006, 55(5), 709-716.
• Cabral DA, Laxer RM, Schrader J, Turvey S, Stevens A, Yeung RSM, Foster HE, Emery H, Prendiville J, Tucker LB, Foeldvari I, Sherry DD, Klinkhoff AB, Wallace CA, Houghton K. Old challenges and new directions in pediatric rheumatology. In: Symposium in Tribute to Dr. Ross Petty. 2006, Department of Pediatrics, University of British Columbia, Vancouver: Journal of Rheumatology, Journal of Rheumatology Publishing Co. Ltd.
• Ruperto N, Ravelli A, Oliveira S, Alessio M, Mihaylova D, Pasic S, Cortis E, Apaz M, Burgos-Vargas R, Kanakoudi-Tsakalidou F, Norambuena X, Corona F, Gerloni V, Hagelberg S, Aggarwal A, Dolezalova P, Saad CM, Bae S, Vesely R, Avcin T, Foster H, Duarte C, Herlin T, Horneff G, Lepore L, Van Rossum M, Trail L, Pistorio A, Andersson-Gare B, Giannini EH, Martini A, Paediat Rheumatology Int Trials Or, Paediat Rheumatology Collaborative. The Pediatric Rheumatology International Trials Organization American-College-of-Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: Prospective validation of the definition of improvement. Arthritis & Rheumatism 2006, 55(3), 355-363.
• Foster HE, Fitzgerald JE. Dental disease in children with chronic illness; what the general paediatrician should know. Archives of Disease in Childhood 2005, 90(7), 703-709.
• Peake NJ, Khawaja K, Myers A, Jones D, Cawston TE, Rowan AD, Foster HE. Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study. Rheumatology 2005, 44(11), 1383-1389.
• Foster HE, Everett S, Myers A. Rheumatology training in the UK: The trainees' perspective. Rheumatology 2005, 44(2), 263-264.
• Waterhouse PJ, Thomason JM, Fitzgerald JL, Foster HE, Steen IN, Welbury RR. The dental attitudes, knowledge and health practices of patients with Juvenile Idiopathic Arthritis. European Journal of Paediatric Dentistry 2005, 6(4), 202-208.
• Foster HE, Khawaja K. When to refer to a paediatric rheumatologist?. Current Paediatrics 2005, 15(1), 1-8.
• Ruperto N, Murray KJ, Gerloni V, Wulffraat N, Oliveira de SKF, Falcini F, Dolezalova P, Alessio M, Burgos-Vargas R, Corona F, Vesely R, Foster HE, Davidson J, Zulian F, Asplin L, Baildam E, Consuegra JG, Ozdogan H, Saurenmann R, Joos R, Pistorio A, Woo P, Martini A, Knupp S. A Randomized Trial of Methotrexate Comparing an Intermediate Dose With a Higher Dose in Children With Juvenile Idiopathic Arthritis Who Failed to Respond to Standard Doses of Methotrexate. Arthritis & Rheumatism 2004, 50(7), 2191-2201.
• De Kleer IM, Brinkman DMC, Ferster A, Abinun M, Quartier P, Van Der Net J, Ten Cate R, Wedderburn LR, Horneff G, Oppermann J, Zintl F, Foster HE, Prieur AM, Fasth A, Van Rossum MAJ, Kuis W, Wulffraat NM. Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: Analysis of clinical effects, mortality, and transplant related morbidity. Annals of the Rheumatic Diseases 2004, 63(10), 1318-1326.
• Myers A, McDonagh JE, Gupta K, Hull R, Barker D, Kay LJ, Foster HE. More 'cries from the joints': Assessment of the musculoskeletal system is poorly documented in routine paediatric clerking. Rheumatology 2004, 43(8), 1045-1049.
• Wood M, Abinun M, Foster HE. Pyrexia of unknown origin. Probelm solving in clinical practice. Archives of Disease in Childhood: Education and Practice Edition 2004, 89(3), ep63-ep69.
• Wedderburn LR, Abinun M, Palmer P, Foster HE. Autologous haematopoietic stem cell transplantation in juvenile idiopathic arthritis. Archives of Disease in Childhood 2003, 88(3), 201-205.
• Foster H, Kay L. Examination skills in the assessment of the musculoskeletal system in children and adolescents. Current Paediatrics 2003, 13(5), 341-344.
• Welbury RR, Thomason JM, Fitzgerald JL, Steen IN, Marshall NJ, Foster HE. Increased prevalence of dental caries and poor oral hygiene in juvenile idiopathic arthritis. Rheumatology 2003, 42(12), 1445-1451.
• Wedderburn LR, Patel A, King D, Varsani H, Foster HE, Abinun MA. Long term follow up immune repertoire after severe immunosuppression and autologous stem cell transplantation (ASCT) in children with juvenile idiopathic arthritis (JIA). Clinical and Experimental Rheumatology 2003, 21(4), 537.
• Wedderburn LR, Patel A, King D, Varsani H, Foster HE, Abinun MM. Long term follow up of immune repertoire after severe immunosuppression and autologous stem cell rescue in children with juvenile idiopathic arthritis. In: Arthritis & Rheumatism: 67th Annual Scientific Meeting of the American College of Rheumatology. 2003, Orlando, Florida, USA: John Wiley & Sons, Inc.
• Wulffraat NM, Brinkman D, Ferster A, Opperman J, ten Cate R, Wedderburn L, Foster H, Abinun M, Prieur AM, Horneff G, Zintl F, de Kleer I, Kuis W. Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis. In: Conference on Stem Cells for Tolerance and Tissue Regeneration. 2003, Snowbird, Utah: Bone Marrow Transplantation, Nature Publishing Group.
• Myers A, McDonagh JE, Gupta K, Hull R, Barker D, Kay LJ, Foster HE. Multicentre Audit of Musculoskeletal Examination in General Paediatrics. Rheumatology 2003, 42(S1), 50.
• Kay LJ, Baggott G, Coady DA, Foster HE. Musculoskeletal examination for children and adolescents: Do standard textbooks contain enough information? [8]. Rheumatology 2003, 42(11), 1423-1425.
• Foster HE, Marshall N, Myers A, Dunkley P, Griffiths ID. Outcome in adults with juvenile idiopathic arthritis: A quality of life study. Arthritis and Rheumatism 2003, 48(3), 767-775.
• Ruperto N, Murray KJ, Gerloni V, Wulffraat N, de Oliveira SKF, Falcini F, Dolezalova P, Alessio M, Burgos-Vargas R, Corona F, Vesely R, Foster H, Davidson J, Zulian F, Asplin L, Baildam E, Consuegra JG, Ozdogan H, Saurenmann R, Joos R, Pistorio A, Woo P, Martin A, for the Pediatric Rheumatology International Trials Organization (PRINTO). Preliminary core sets measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology 2003, 42(12), 1452-1460.
• Eltringham ME, Myers A, Friswell M, Abinun MA, Kay LJ, Foster HE. Referral delays for children with juvenile idiopathic arthritis. Clinical and Experimental Rheumatology 2003, 21(4), 532.
• Fitzgerald JL, Welbury RR, Thomason JM, Foster HE. The prevalence of enamel opacities in juvenile idiopathic arthritis (jia). In: Journal of Dental Research: 1st Annual Meeting of the International Association for Dental Research. 2003, Cardiff, UK: Sage Publications, Inc.
• Walton AG, Welbury RR, Foster HE, Wright WG, Thomason JM. Sialochemistry in juvenile idiopathic arthritis. Oral Diseases 2002, 8(6), 287-290.
• Myers A, Clark J, Foster H. Tuberculosis and treatment with infliximab. New England Journal of Medicine 2002, 346(8), 625.
• Myers AJ, Clarke J, Foster HE. Tuberculous septic arthritis and etanercept in juvenile idiopathic arthritis. New England Journal of Medicine 2002, 346(8), 625.
• Welbury RR, Thomason JM, Fitzgerald JL, Steen IN, Foster HE. Type and extent of enamel defects in juvenile idiopathic arthritis (JIA). European Journal of Paediatric Dentistry 2002, 3(4), 217-221.
• Nugent J, Ruperto N, Grainger J, Machado C, Sawhney S, Baildam E, Davidson J, Foster H, Hall A, Hollingworth P, Sills J, Venning H, Walsh JE, Landgraf JM, Roland M, Woo P, Murray KJ, Paediatric Rheumatology International Trials Organisation. The British version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clinical and Experimental Rheumatology 2001, 19(4 (supp 23)), S163-S167.
• McDonagh JE, Foster HE, Hall MA, Chamberlain MA. Audit of rheumatology services for adolescents and young adults in the UK. Rheumatology 2000, 39(6), 596-602.
• McDonagh JE, Foster HE, Hall MA, Chamberlain MA, Brit Paediat Rheumatology Grp. Audit of rheumatology services for adolescents and young adults in the UK. Rheumatology 2000, 39(6), 596-602.
• Bartram S, Foster H, Francis R. Bone mineral density and juvenile chronic arthritis: comment on the article by Zak et al. Arthritis and Rheumatism 2000, 43(3), 710-710.
• Abinun, M., Foster, H. E., Ramesh, V., Craft, A. W. Heterogeneity of juvenile dermatomyositis. The Lancet 2000, 355(9210), 1186-1186.
• Foster H, Marshall N. JCA in adult life: a study of long-term outcome in patients with JCA or adult RA. Clinical Rheumatology 2000, 19(4), 326-329.
• Walton AG, Thomason JM, Welbury RR, Foster HE. Oral health and juvenile idiopathic arthritis: a review. Rheumatology 2000, 39(5), 550-555.
• Foster HE, Marshall NJ. The outcome of Juvenile Idiopathic Arthritis in adulthood. Clinical Rheumatology 2000, 19(4), 326-328.
• Foster HE, Welbury RR, Fitzgerald Jl, Stephenson S, Thomason JM. Increased prevalence of poor oral health in juvenile idiopathic arthritis. JADA 1999, 130 (12), 1694-1695.
• Walton AG, Welbury RR, Foster HE, Thomason JM. Juvenile chronic arthritis: A dental review. Oral Diseases 1999, 5(1), 68-75.
• Foster H. Rheumatoid arthritis and children. Journal of the American Dental Association 1999, 130(12), 1694-1695.
• Foster HE. Chronic Arthritis in children and adolescents. Medicine 1998, 26(6), 63-67.
• Foster HE, Petty RE. Chronic Arthritis in children and adolescents. Medicine 1998, 26(6), 63-67.
• Hudson B, Clarke M, Strong NP, Abinun M, Craft AW, Foster HE. An audit of screening for chronic anterior uveitis in juvenile chronic arthritis. British Journal of Rheumatology 1997, 36(Supplement 2), 17.
• Foster HE, Petty RE, Malleson PN, Cabral DA. Anti-RNP antibody in a child with metastatic carcinoma and no evidence of Mixed Connective Tissue Disease. Br J Rheumatol 1997, 36, 289-291.
• Foster HE. Management of arthritis and joint pain in adolescents. . Prescriber 1997, 8(1), 23-29.
• Foster HE, Malleson PN, Roberton DM, Petty RE, Cabral DA. Pneumocystis carinii pneumonia in children with SLE. J Rheumatol 1996, 23, 753-756.
• Foster HE, Cabral DA, Malleson PN, Cairns R, Burnell RH, Roberton DM, Petty RE. Atlanto-axial subluxation in seronegative enthesopathy and arthritis (SEA) syndrome in children. J Rheumatol 1995, 22, 548-552.
• Guo K, Major G, Foster H, Bassendine M, Collier J, Ross D, Griffiths I. Defective repair of O6-methylguanine DNA in Primary Sjogren’s syndrome patients predisposed to lymphoma. Ann Rheum Dis 1995, 54, 229-232.
• Foster HE, Gilroy JJ, Kelly CA, Howe J, Griffiths ID. The treatment of sicca symptoms in Sjogren’s syndrome; a suggested approach. Br J Rheumatol 1994, 32, 86-90.
• Foster HE, Stephenson A, Walker DJ, Kelly C, Griffiths ID. Linkage studies of HLA and Primary Sjogren's syndrome in multicase families. Arthritis Rheum 1993, 36(4), 473-484.
• Foster HE, Calvert JE, Kelly CA, Griffiths ID. The levels of CD5+ B cells are not increased in probands with Primary Sjogren's syndrome or their relatives. Autoimmunity 1993, 5, 93-97.
• Foster HE, Kelly CA, Fay A, Charles PJ, Walker DJ, Griffiths ID. Thyroid disease and other autoimmune phenomena in a family study of Primary Sjogren's syndrome. Br J Rheumatol 1993, 32, 36-40.
• Foster HE, Kelly CA, Cavanagh G, Charles PJ, Walker DJ, Griffiths ID. Association of HLA-DR3 with susceptibility and severity of Primary Sjogren's syndrome in a family study. Br J Rheumatol 1992, 31, 309-315.
• Kay RA, Thomson W, Hay EM, Dyer PA, Green LM, Foster HE, Holt PJL, Bernstein RM, Griffiths ID, Pumphrey RSH, Boylston AW, Ollier WER. The influence of HLA and Primary Sjogren's syndrome on Vß6.7 T cell receptor gene expression. In: Proceedings of the 11th International Histocompatibility Workshop and Conference. 1992, Oxford University Press.
• Kelly CA, Foster HE, Pal B, Gardner PJ, Malcolm A, Howe J, Blair G, Dick WC, Griffiths ID. Primary Sjogren's syndrome in North East England - a longitudinal study. Br J Rheumatol 1991, 30, 437-442.
• Foster HE, Pyle C, Walker DJ. Severe disability due to arthritis in the community - an audit. Br J Rheumatol 1991, 30, 356-360.
• Foster HE, Deighton CM, Griffiths ID. Sex ratios in HLA related autoimmune disease. Ann Rheum Dis 1991, 50(12), 969.
• Myszor M, Hosker H, Foster HE. Alcohol and health: do we know enough?. Health Trends 1990, 22(1), 23-26.